SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-20-002900
Filing Date
2020-11-12
Accepted
2020-11-12 17:11:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G sc13ga107422calt_11122020.htm SC 13G/A 281021
  Complete submission text file 0000921895-20-002900.txt   282573
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, C8 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91523 | Film No.: 201307946
SIC: 2834 Pharmaceutical Preparations